(Total Views: 157)
Posted On: 03/08/2022 11:10:51 AM
Post# of 24

$CRTX News Article - Cortexyme Reports Safety and Pharmacokinetics Results from Single Ascending Dose Portion of its Phase 1 Clinical Trial of COR588 https://marketwirenews.com/news-releases/cort...56162.html


My Twitter: WhyteStocks